nasdaqpicks.com
Type your search query and hit enter:
Epigral derivative and specialty products
Business
Epigral targets 20% annual growth, expects to more than double revenue by FY28
Epigral Ltd aims to grow at an annual rate of 20 per cent and is poised to more than double…
24 hours ago